Product Information
GENGRAF 100 MG CAPSULE is a brand (anda) product labeled by AbbVie Inc., priced at $7.4212 per EA under NDC 00074310932. Its NADAC has been published 100 times since Apr 17, 2024.
Strength
100 mg/1
Manufacturer
AbbVie Inc.NDC
00074310932
Classification
Brand (ANDA)
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/2/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065003On Market Since
11/1/2015
Pharmacological Classes
Price Statistics
The NADAC for GENGRAF 100 MG CAPSULE has been published 100 times since Apr 17, 2024, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4212 per EA |
|---|---|
| All-time high | $7.4212 (Mar 11, 2026) |
| All-time low | $6.6896 (Apr 17, 2024) |
| 52-week high | $7.4212 |
| 52-week low | $7.0678 |
| Median price | $7.0678 |
| Average price | $6.9655 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 100 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GENGRAF 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GENGRAF 100 MG CAPSULE, manufactured by AbbVie Inc., is $7.4212 per EA (NDC 00074310932), effective Mar 11, 2026.
How has the price of GENGRAF 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GENGRAF 100 MG CAPSULE has risen 10.9%. It has been tracked across 100 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GENGRAF 100 MG CAPSULE?
Since Apr 17, 2024, the NADAC for GENGRAF 100 MG CAPSULE has ranged from a low of $6.6896 (Apr 17, 2024) to a high of $7.4212 (Mar 11, 2026), with a median of $7.0678 per EA.
Are there cheaper alternatives to GENGRAF 100 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 100 MG, is $1.2400 per EA — about 83% below GENGRAF 100 MG CAPSULE.
Who manufactures GENGRAF 100 MG CAPSULE?
GENGRAF 100 MG CAPSULE (NDC 00074310932) is labeled by AbbVie Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification